https://orcid.org/0000-0002-7170-5636
References
- National Intitue for Health and Care Excellence. Abortion care (NG140). NICE; 2019. Available from: https://www.nice.org.uk/guidance/NG140.
- Chief Medical Officer for Scotland. Abortion – Covid-19 – approval for mifepristone to be taken at home and other contingency measures. 2020. Available from: https://www.sehd.scot.nhs.uk/cmo/CMO%282020%2909.pdf.
- Royal College of Obstetricians and Gynaecologists. Coronavirus (COVID-19) infection and abortion care. 2020. Available from: https://www.rcog.org.uk/en/guidelines-research-services/guidelines/coronavirus-abortion/.
- Reynolds-Wright JJ, Johnstone A, McCabe K, et al. Telemedicine medical abortion at home under 12 weeks’ gestation: a prospective observational cohort study during the COVID-19 pandemic. BMJ Sex Reprod Health. 2021;47(4):246–246.
- The Faculty for Sexual and Reproductive Healthcare (FSRH). Clinical guideline: contraception after pregnancy. FSRH, 2017. (Amended October 2020). Available from: https://www.fsrh.org/standards-and-guidance/documents/contraception-after-pregnancy-guideline-january-2017/.
- Royal College of Obstetricians and Gynaecologists. The care of patients requesting induced abortion (Evidence-based Clinical Guideline Number 7). 2011. Available from: https://www.rcog.org.uk/globalassets/documents/guidelines/abortion-guideline_web_1.pdf.
- National Collaborating Centre for Patients’s and Children’s Health. Long acting reversible contraception (clinical guideline 30). London: NICE; 2005; [Updated 2019]. Available from: https://www.rcog.org.uk/en/guidelines-research-services/guidelines/long-acting-reversible-contraception-update-nice-clinical-guideline-30/
- Stangroom J. Chi Square Calculator. 2021. Available from: https://www.socscistatistics.com/tests/chisquare2/default2.aspx.
- Finch RE, McGeechan K, Johnstone A, et al. Impact of self-administration of misoprostol for early medical abortion: a prospective observational cohort study. BMJ Sex Reprod Health. 2019;45(4):296–301.
- Cameron S, Glasier A, McDaid L, et al. Use of effective contraception following provision of the progestogen-only pill for patients presenting to community pharmacies for emergency contraception (Bridge-It): a pragmatic cluster-randomised crossover trial. Lancet. 2020;396(10262):1585–1594.
- The Faculty of Sexual and Reporductive Healthcare (FSRH). FSRH statement: FSRH guidance essential SRH services during a third COVID-19 lockdown in the UK and beyond. FSHR, 2021. Available from: https://www.fsrh.org/documents/fsrh-guidance-essential-srh-services–third-covid-19-lockdown/
- Cameron ST, Berugoda N, Johnstone A, et al. Assessment of a ‘fast-track’ referral service for intrauterine contraception following early medical abortion. J Fam Plann Reprod Health Care. 2012;38(3):175–178.
- Cameron S. Postabortal and postpartum contraception. Best Pract Res Clin Obstet Gynaecol. 2014;28(6):871–880.
- Stanek AM, Bednarek PH, Nichols MD, et al. Barriers associated with the failure to return for intrauterine device insertion following first-trimester abortion. Contraception. 2009;79(3):216–220.
- Hognert H, Kallner H, Cameron S, et al. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion – a randomized controlled equivalence trial. Hum. Reprod. 2016;31(11):2484–2490.
- Smith C, Ly S, Uk V, et al. Women’s views and experiences of a mobile phone-based intervention to support post-abortion contraception in Cambodia. Reprod Health. 2017;14(1):72.
- The Faculty for Sexual and Reproductive Healthcare (FSRH). FSRH statement: Data shows deep impact of COVID-19 on access to contraception in the community [press release]. FSRH, 2020. Available from: https://www.fsrh.org/news/fsrh-statement-data-impact-covid19-access-contraception-2020/